The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 13, 2021

Filed:

Mar. 15, 2017
Applicant:

Max-delbrück-centrum Für Molekulare Medizin IN Der Helmholtz-gemeinschaft, Berlin-Buch, DE;

Inventors:

Wolfgang Uckert, Berlin, DE;

Mario Bunse, Berlin, DE;

Julian Clauss, Berlin, DE;

Zsuzsanna Izsvák, Berlin, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/04 (2006.01); C07K 14/725 (2006.01); C12N 15/85 (2006.01); C12N 9/12 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); C12N 5/10 (2006.01); C12N 15/113 (2010.01); C12N 15/90 (2006.01);
U.S. Cl.
CPC ...
C07K 14/7051 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C12N 5/10 (2013.01); C12N 9/1241 (2013.01); C12N 15/113 (2013.01); C12N 15/85 (2013.01); C12N 15/90 (2013.01); C12Y 207/07 (2013.01); C12N 2800/22 (2013.01); C12N 2800/24 (2013.01); C12N 2800/90 (2013.01); C12N 2840/20 (2013.01);
Abstract

The present invention relates to the field of genetic engineering, in particular, to a transposon-based transfection kit suitable for transfection of primary cells, such as T cells, comprising mRNA encoding a transposase, or reagents for generating mRNA encoding said transposase, as well as minicircle DNA comprising the transposon. The invention also relates to a nucleic acid, preferably, a DNA minicircle, comprising a transposon, wherein the transposon encodes a protein and at least one miRNA, wherein the sequences encoding the miRNA are located in an intron and expression of the protein and the miRNA is regulated by the same promoter. The invention also provides a population of cells obtainable with the method of the invention. Methods of transfection are also provided, as well as medical use, e.g. in immunotherapy, in particular, in adoptive T cell therapy or T cell receptor (TCR) or chimeric antigen receptor (CAR) gene therapy.


Find Patent Forward Citations

Loading…